Russia drowns in anxiety – medications are being sold like hotcakes. Since the beginning of 2025, antidepressant sales in Russia have surged amid the war against Ukraine and ongoing economic problems, according to Ukraine’s Foreign Intelligence Service.

From January to July, pharmacy chains sold 12.9 million packs of such medications worth $118 million, a 36% increase in monetary terms compared to the previous year.

Sales of anxiolytics, which reduce anxiety, rose 10% in the first half of the year, exceeding 9.3 million packs.

Doctors report an increase in patients experiencing symptoms of depression, panic attacks, insomnia, and drug dependence.

Pressure from electronic draft notices and social anxiety

The rise in demand for psychiatric drugs coincides with a large-scale campaign to create a register of military conscripts.

Since July, Russians have been receiving mass notifications about being added to the database, including female medical workers, teenagers, and people with limited fitness.

The Russian parliament emphasizes that the rollout of electronic draft notices does not signify the start of mobilization, but these messages have become a key driver of societal anxiety.

Earlier, Euromaidan Press reported that the Kremlin seeks to avoid repeating the social upheavals that followed the Soviet war in Afghanistan and is attempting to control demobilisation from Ukraine’s war. 

A high number of veterans with PTSD are returning home, posing dangers to their families.

Among the demobilized are individuals who have already served prison terms, including thieves, murderers, and rapists.